METHOTREXATE INJECTION USP DIN 02182947
Status: Marketed
Holder: PFIZER CANADA ULC
Molecule: METHOTREXATE (METHOTREXATE SODIUM)
Available to quote
Health Canada record
| Active ingredient(s) | METHOTREXATE (METHOTREXATE SODIUM) 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intracerebroventricular; Intra-Arterial; Intramuscular; Intrathecal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01BA01 METHOTREXATE |
| Original market date | 30-Jul-1997 |
| Current status date | 06-Jun-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHOTREXATE (METHOTREXATE SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02530767 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Approved |
| 02530856 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02530848 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 22.5 MG | Marketed |
| 02530813 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed |
| 02530805 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 17.5 MG | Marketed |
| 02530791 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed |
| 02530783 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 12.5 MG | Marketed |
| 02530775 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed |
| 02283697 | METHOTREXATE | APOTEX INC | Tablet | METHOTREXATE (METHOTREXATE SODIUM) 2.5 MG | Approved |
| 02474891 | METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02474735 | METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02464365 | METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02333023 | METHOTREXATE INJECTION BP | UMAN PHARMA INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Approved |
| 02327236 | METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02182971 | METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02182777 | METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02182955 | METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02422182 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed |
| 02422166 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Marketed |
| 02422174 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed |
| 02422190 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed |
| 02422204 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02099705 | METHOTREXATE SODIUM INJECTION | TEVA CANADA LIMITED | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02491362 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02491354 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 22.5 MG | Marketed |
| 02491346 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed |
| 02491338 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 17.5 MG | Marketed |
| 02491311 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed |
| 02491303 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 12.5 MG | Marketed |
| 02491281 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed |
| 02491273 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Approved |
| 02454831 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed |
| 02454750 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 12.5 MG | Marketed |
| 02454769 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 17.5 MG | Marketed |
| 02454777 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 22.5 MG | Marketed |
| 02454823 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Approved |
| 02454858 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed |
| 02454866 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed |
| 02454874 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed |
| 02419173 | JAMP-METHOTREXATE | JAMP PHARMA CORPORATION | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 00614335 | METHOTREXATE DBL INJ 10MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Cancelled Post Market |
| 00614327 | METHOTREXATE DBL INJ 2.5MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | METHOTREXATE (METHOTREXATE SODIUM) 2.5 MG | Cancelled Post Market |
| 00614343 | METHOTREXATE DBL INJ 25MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 02398427 | METHOTREXATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 02417626 | METHOTREXATE INJECTION, USP | STRIDES PHARMA CANADA INC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Dormant |
| 02377624 | METHOTREXATE PF/SA INJECTION | SANDOZ CANADA INCORPORATED | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Pre Market |
| 02084481 | METHOTREXATE SOD INJ 25MG/ML USP | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 00410195 | METHOTREXATE SODIUM INJ 20MG | LEDERLE CYANAMID CANADA INC. | Powder For Solution | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Cancelled Post Market |
| 00321397 | METHOTREXATE SODIUM INJ 25.0MG/ML | LEDERLE CYANAMID CANADA INC. | Liquid | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 01911457 | METHOTREXATE SODIUM INJ 25MG/ML USP | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 02161168 | METHOTREXATE SODIUM INJECTION USP | PFIZER CANADA ULC | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 02170663 | METHOTREXATE-LIQ IM IV IAR INT IVR 25MG/ML | WYETH-AYERST CANADA INC. | Liquid | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 02170655 | METHOTREXATE-PWS IM IV IAR INT IVR 20MG/VIAL | WYETH-AYERST CANADA INC. | Powder For Solution | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Cancelled Post Market |
| 02304767 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Cancelled Post Market |
| 02320045 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Cancelled Post Market |
| 02320053 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market |
| 02320029 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Cancelled Post Market |
| 02320037 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Cancelled Post Market |
| 02244798 | RATIO-METHOTREXATE SODIUM | TEVA CANADA LIMITED | Tablet | METHOTREXATE (METHOTREXATE SODIUM) 2.5 MG | Cancelled Post Market |
| 02171767 | RHEUMATREX-TAB 2.5MG | WYETH-AYERST CANADA INC. | Tablet | METHOTREXATE (METHOTREXATE SODIUM) 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19386 | 2017-06-06 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 8870 | 2007-06-28 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 2847 | 2003-06-20 | Supplement to a New Drug Submission (SNDS) | PRODUCT NAME CHANGE FROM METHOTREXATE SODIUM INJECTION USP |
| 668 | 2002-10-24 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 5130 | 1995-10-02 | New Drug Submission (NDS) |